Vitale, Antonio <br/><br/>
Anakinra treatment in patients with gout and type 2 diabetes.  [electronic resource] 

 -  Clinical rheumatology  May 2015 
 - 981-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1434-9949 
<br/><br/><label>Standard No.: </label>10.1007/s10067-014-2601-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Allopurinol--therapeutic use<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Blood Glucose--metabolism<br/>Carbamates--therapeutic use<br/>Colchicine--therapeutic use<br/>Diabetes Mellitus, Type 2--complications<br/>Febuxostat--therapeutic use<br/>Glycated Hemoglobin--metabolism<br/>Gout--complications<br/>Gout Suppressants--therapeutic use<br/>Humans<br/>Hyperuricemia--blood<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--therapeutic use<br/>Interleukin 1 Receptor Antagonist Protein--therapeutic use<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Piperidines--therapeutic use<br/>Treatment Outcome<br/>Uric Acid--blood